AstraZeneca (AZN) RNS Announcements

Add to Alert list
Date Time Source Announcement
18 Jan 2011 07:00 AM
RNS
Transaction in Own Shares
17 Jan 2011 07:00 AM
RNS
Transaction in Own Shares
14 Jan 2011 07:00 AM
RNS
Transaction in Own Shares
13 Jan 2011 07:00 AM
RNS
Transaction in Own Shares
12 Jan 2011 07:00 AM
RNS
Transaction in Own Shares
11 Jan 2011 07:00 AM
RNS
Transaction in Own Shares
10 Jan 2011 07:00 AM
RNS
Transaction in Own Shares
07 Jan 2011 07:00 AM
RNS
Transaction in Own Shares
06 Jan 2011 07:00 AM
RNS
Transaction in Own Shares
05 Jan 2011 07:00 AM
RNS
Transaction in Own Shares
04 Jan 2011 04:00 PM
RNS
Total Voting Rights
24 Dec 2010 07:00 AM
RNS
Transaction in Own Shares
23 Dec 2010 02:30 PM
RNS
Share Repurchase Programme
23 Dec 2010 07:00 AM
RNS
Transaction in Own Shares
23 Dec 2010 07:00 AM
RNS
Ends Agreement with Abbott fo
22 Dec 2010 07:00 AM
RNS
Transaction in Own Shares
21 Dec 2010 07:00 AM
RNS
Update re motavizumab
21 Dec 2010 07:00 AM
RNS
Transaction in Own Shares
20 Dec 2010 07:00 AM
RNS
Transaction in Own Shares
17 Dec 2010 05:15 PM
RNS
Directorate Change
17 Dec 2010 07:00 AM
RNS
Complete Response Letter from
16 Dec 2010 07:00 AM
RNS
Transaction in Own Shares
14 Dec 2010 07:00 AM
RNS
Transaction in Own Shares
13 Dec 2010 07:00 AM
RNS
Transaction in Own Shares
10 Dec 2010 07:00 AM
RNS
Transaction in Own Shares
09 Dec 2010 07:00 AM
RNS
Transaction in Own Shares
08 Dec 2010 07:00 AM
RNS
Transaction in Own Shares
07 Dec 2010 07:00 AM
RNS
Transaction in Own Shares
06 Dec 2010 07:00 AM
RNS
EC approves Brilique tablets
06 Dec 2010 07:00 AM
RNS
Transaction in Own Shares
03 Dec 2010 07:00 AM
RNS
Transaction in Own Shares
02 Dec 2010 07:00 AM
RNS
Transaction in Own Shares
01 Dec 2010 05:00 PM
RNS
Director/PDMR Shareholding
01 Dec 2010 04:00 PM
RNS
Total Voting Rights
01 Dec 2010 07:00 AM
RNS
Transaction in Own Shares
30 Nov 2010 07:00 AM
RNS
Transaction in Own Shares
29 Nov 2010 07:00 AM
RNS
Transaction in Own Shares
26 Nov 2010 07:00 AM
RNS
Transaction in Own Shares
25 Nov 2010 07:00 AM
RNS
Transaction in Own Shares
24 Nov 2010 07:00 AM
RNS
Transaction in Own Shares
23 Nov 2010 07:00 AM
RNS
Transaction in Own Shares
22 Nov 2010 07:00 AM
RNS
Transaction in Own Shares
19 Nov 2010 07:00 AM
RNS
Transaction in Own Shares
18 Nov 2010 04:00 PM
RNS
Director/PDMR Shareholding
18 Nov 2010 07:00 AM
RNS
Transaction in Own Shares
17 Nov 2010 04:00 PM
RNS
Director/PDMR Shareholding
17 Nov 2010 07:00 AM
RNS
Transaction in Own Shares
16 Nov 2010 04:00 PM
RNS
Director/PDMR Shareholding
16 Nov 2010 07:00 AM
RNS
Transaction in Own Shares
15 Nov 2010 07:00 AM
RNS
Transaction in Own Shares

AstraZeneca plc is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England.

It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation. It was involved in developing the Oxford–AstraZeneca COVID-19 vaccine.

Astra Zeneca share price launched at 605p in 1993.

UK 100

Latest directors dealings